Comparing Ginkgo Biloba and Desmopressin for treating bedwetting in children
Ginkgo Biloba Versus Desmopressin in Treatment of Children with Monosymptomatic Nocturnal Enuresis: a Randomized Prospective Study
This study is testing whether Ginkgo Biloba or Desmopressin works better to help children who wet the bed at night.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 5 Years to 18 Years |
| Sex | All |
| Sponsor | Menoufia University Academic / other |
| Locations | 1 site (Shebin El-Kom, Menoufia) |
| Trial ID | NCT06771128 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Ginkgo Biloba compared to Desmopressin in treating children with monosymptomatic nocturnal enuresis, a common condition characterized by bedwetting. The research aims to determine which treatment is more effective in reducing episodes of bedwetting. Ginkgo Biloba is an herbal supplement known for its potential benefits in improving sleep rhythm and reducing oxidative stress, while Desmopressin is a synthetic hormone commonly used for this condition. The study will involve administering either Ginkgo Biloba or Desmopressin to eligible children and monitoring their progress over time.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with monosymptomatic nocturnal enuresis.
Not a fit: Children who experience both day and night wetting may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a safer and effective alternative treatment for children suffering from bedwetting.
How similar studies have performed: While there have been studies on the use of Desmopressin for nocturnal enuresis, the use of Ginkgo Biloba in this context is less common and may represent a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all children with monosymptomatic nocturnal enuresis. Exclusion Criteria: * children with day and night wetting.
Where this trial is running
Shebin El-Kom, Menoufia
- Menoufia Faculty of Medicine — Shebin El-Kom, Menoufia, Egypt (Recruiting)
Study contacts
- Study coordinator: Ammar F Alorabi
- Email: ammar.alorabi95@gmail.com
- Phone: +201067608011
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.